| Name | Value |
|---|---|
| Revenues | 0.0M |
| Cost of Revenue | 0.0M |
| Gross Profit | 0.0M |
| Operating Expense | -48.6M |
| Operating I/L | 48.6M |
| Other Income/Expense | -60.3M |
| Interest Income | 0.0M |
| Pretax | -11.7M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -11.7M |
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company specializing in diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. The company's Alpha-DaRT technology is utilized in clinical trials for skin, oral, pancreatic, and breast cancers, as well as in preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.